Latest Breaking News On - Genomics group president sam raha - Page 1 : vimarsana.com

The clearance applies to use of the companion diagnostic to identify patients with multiple cancer types for treatment with Merck's Keytruda and Regeneron's Libtayo.

Regeneron libtayoJenipher daltonSam rahaMerck keytrudaAgilent technologiesEuropean medicines agencyGenomics groupGenomics group president sam rahaEuropean medicines